Anti-IL-12p40 and anti-IL-23p19 ameliorate Helicobacter hepaticus-induced innate colitis and Il10-/- colitis (96–98); anti-IL-12p40 and anti-IL-23p19 (clinical improvement in CD and UC) (99–101). Here, IL10 is linked to colitis.